Grand Pharmaceutical Group Limited Stock OTC Markets
Stocks
CGPHF
BMG210A71016
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 06-05 | Grand Pharmaceutical Group Limited Declares Final Dividend for the Year Ended 31 December 2025 | CI |
| 04-14 | Grand Pharmaceutical Says Liver Cancer Treatment Reaches Clinical Endpoint | MT |
| Market Cap | 18.07B 2.3B 2.01B 1.86B 1.71B 3.23B 222B 3.3B 22.21B 8.73B 109B 8.66B 8.46B 374B | P/E 2026 * |
9.56x | P/E 2027 * | 8.64x |
|---|---|---|---|---|---|
| Enterprise Value | 18.07B 2.3B 2.01B 1.86B 1.71B 3.23B 222B 3.3B 22.21B 8.73B 109B 8.66B 8.46B 374B | EV / Sales 2026 * |
1.35x | EV / Sales 2027 * | 1.22x |
| Free-Float |
23.76% | Yield 2026 * |
4.65% | Yield 2027 * | 5.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 36 | 01/06/2021 |
Tin Chung Foo
SEC | Corporate Secretary | 57 | 01/09/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 63 | 21/03/2005 |
Ye Bi Hu
BRD | Director/Board Member | 62 | 31/12/2018 |
Geng Pei
BRD | Director/Board Member | 66 | 12/05/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.3B | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.06% | +0.54% | +28.13% | +55.82% | 397.23B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.75% | +81.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.34B 1.7B 1.49B 1.37B 1.26B 2.38B 164B 2.44B 16.4B 6.45B 80.24B 6.39B 6.25B 276B | 14.78B 1.89B 1.65B 1.52B 1.4B 2.64B 182B 2.7B 18.17B 7.14B 88.91B 7.08B 6.92B 306B |
| Net income | 1.91B 244M 213M 197M 181M 342M 23.49B 350M 2.35B 925M 11.51B 916M 896M 39.62B | 2.09B 266M 233M 215M 198M 373M 25.62B 381M 2.56B 1.01B 12.55B 999M 977M 43.21B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 512 Stock
- CGPHF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
